Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
T138067-Sodium in Second-Line NSCLC
NCT00022243Phase 2Unknown
- Sponsor
- Tularik Inc.
- Start
- Oct 2000
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of batabulin in non-small cell lung cancer (NSCLC), sponsored by Tularik Inc.. Status: unknown.
02
Drugs
batabulin
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00022243.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00022243.